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Introduction
Sensorineural hearing loss and vertigo occur when there
is damage to the inner ear (cochlea and vestibule) or
to the nerve pathways from the inner ear to the brain
(retrocochlear pathways). They may be caused by vas-
cular problems, viral infections, autoimmune diseases,
ototoxic medications, or genetic syndromes, or they
may occur as a result of noise exposure, head trauma,
aging, or, more seriously, tumors.1 We report this case
of asymptomatic primary pulmonary adenocarcinoma
with brain metastases presenting as sudden hearing loss
and vertigo.
Case Report
The 59-year-old male patient came to our outpatient
department for help with the chief complaint of
episodic vertigo, dizziness with unsteady gait, left-sided
tinnitus and hearing impairment of 3 weeks’ duration.
No other neurologic symptoms were observed. There
was neither history of previous malignancies nor clinical
evidence of a current malignant tumor. Pure tone au-
diometry revealed left-sided sensorineural hearing loss
(Figure 1).
The patient was admitted under the tentative diag-
nosis of left-sided labyrinthritis. Routine chest X-ray
showed a right suprahilar lobulated soft tissue mass
and bilateral pulmonary nodules (Figure 2). Radio-
logically, these lesions were interpreted as malignancy
with lung-to-lung metastasis. Further thoracic and
upper abdominal computed tomographic scans revealed
a space-occupying (6.5 × 5.5 cm), contrast-enhanced
lesion in the right upper lung. Multiple small nodules,
in favor of metastasis, were also found in both lung
fields and bilateral adrenal glands (Figure 3).
Brain magnetic resonance imaging (MRI) was
arranged to rule out central vertigo due to the persis-
tent and progressive symptoms and revealed multiple
enhanced nodules in the cerebrum, cerebellum, and
left internal auditory canal (Figure 4). Bronchoscopic
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biopsy of the suprahilar mass confirmed pulmonary
adenocarcinoma with clinical stage T3N3M1 (stage IV).
Subsequently, chemoradiotherapy for primary tumor
and metastatic lesions was arranged.
Discussion
Sensorineural hearing loss and vertigo are very common
complaints in otorhinolaryngologists’ clinical experi-
ence. In most cases, the etiology is peripheral in ori-
gin and the symptoms are usually not aggravated after
medical treatment or observation. Vestibular schwan-
noma is the most frequent lesion of the internal acous-
tic canal (IAC) and cerebellar-pontine angle (CPA),
and constitutes more than 80% of all lesions.
Primary metastasis to the IAC is rarely reported,
representing only 0.3% of CPA lesions. The most
common origin in temporal bone metastasis is adeno-
carcinoma of the breast (24.8%), followed by lung
(11.3%), kidney (9.2%), stomach (6.4%), bronchus
(6.4%), and prostate (5.7%).2 There are 3 distinct routes
of tumor spread from the primary tumor to the tem-
poral bone: (1) hematogenous dissemination; (2)
direct neoplastic extension from adjacent areas; and
(3) diffuse metastatic leptomeningeal carcinomatosis
when tumor cells gain access to the cerebrospinal fluid.
Only a few cases of metastasis of lung carcinoma to
the IAC have been reported in the literature.3 Krainik
et al compared the radiological features of different
types of CPA and IAC tumors.4 They pointed out that
the MRI features of metastases are similar to those of
schwannomas except for the presence of thick linear
and extranodular contrast enhancement. Nevertheless,
their study did not allow for definition of precise radio-
logical features that can be used to distinguish between
CPA and IAC lesions, and so the diagnosis of malig-
nancy should rely mainly on clinical signs and findings.
Rapid development of symptoms point to a malignant
neoplasm.
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Figure 1. Pure tone audiometry shows left-sided sensorineural
hearing loss.
Figure 2. Chest X-ray shows right suprahilar tumor (thick arrow)
and contralateral nodule (thin arrow).
Figure 3. Computed tomography of the chest shows right upper
lobe tumor (thick arrow) with suspected contralateral multiple
metastatic nodules (thin arrow).
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Brain metastases, the most common intracranial
tumor, have been reported to occur in 20–45% of pa-
tients with systemic cancer.5 Among adults, the most
common origins of brain metastasis include lung cancer
(50%), breast cancer (15–20%), and melanoma (10%).
Metastases from breast, colon, and renal cell carci-
noma are often solitary, while melanoma and lung
cancer have a greater tendency to lead to multiple
metastases.6,7 Most brain metastases arise from hema-
togenous spread, and thus the distribution of central
nervous system metastases reflects the blood flow in
the central nervous system, with 80% of metastases in
the cerebrum, 15% in the cerebellum, and 5% in the
brainstem and deep structures.5 The majority of metas-
tases are found in the parietal lobe as a result of the
confluence of the 3 major cerebral arteries, followed
by the frontal and occipital lobes.5,8 Headache is a
common presenting symptom, especially in patients
with multiple lesions or with metastases in the posterior
fossa. Cognitive disturbance and lateralizing symp-
toms, such as hemiparesis, aphasia and visual field dis-
turbance, are common in most patients with brain
metastases. Focal or generalized seizures, which are
the presenting symptoms in approximately 10% of
patients, are more common in patients with multiple
lesions and in patients with melanoma metastases,
occurring in 50% of melanoma patients. Some lesions
(5–10%) present acutely with neurologic symptoms
caused by hemorrhage into the tumor.7 Vestibule-
cochlear dysfunction, which was the only manifestation
in our patient, is rarely reported as the first presenting
symptom in brain metastasis.
Vestibular schwannoma is a slow-growing tumor
that progresses over decades. In this case, sudden
onset of vertigo and hearing impairment developed in
the previously healthy patient and progressed in spite
of medical treatment. In addition to the clinical symp-
toms, multiple contrast-enhanced nodules in the brain,
compatible with metastasis, were also found. In such
patients without a known malignancy, sudden onset
of inner ear-related symptoms might be the first sign
of metastatic IAC disease.
In conclusion, when dealing with persistent
vestibule-cochlear dysfunction, pathologies from cen-
tral origins should be highly suspected and further
evaluation undertaken.
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Figure 4. Magnetic resonance imaging of the brain shows: (A) hyperintense subcortical lesion (arrow); (B) hyperintense lesion in the
internal acoustic canal (arrow).
